Supreme Court of the United States · Official docket →

HZNP Finance Limited, et al. v. Actavis Laboratories UT, Inc.

Paid petition · United States Court of Appeals for the Federal Circuit, No. 2017-2149, 2017-2152, 2017-2153, 2017-2202, 2017-2203, 2017-2206 · judgment October 10, 2019

Certiorari denied · November 2, 2020

Pre-decision estimate: 2% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

Whether the “basic and novel properties” identified in connection with a patent claim’s transitional phrase “consisting essentially of” must independently satisfy the requirements of 35 U.S.C. § 112, ¶ 2, of the Patent Act, and the accompanying “reasonable certainty” standard set forth in Nautilus, Inc. v. Biosig Instruments Inc., 134 S. Ct. 2120 (2014).

Counsel of record

For petitioner
Caryn Carson Borg-Breen
Green, Griffith & Borg-Breen, LLP

For respondent
John Christopher Rozendaal
Sterne, Kessler, Goldstein & Fox P.L.L.C.

Case

Subject area
Economic Activity (estimated from the questions presented, in the Supreme Court Database’s categories)

Conference history
Distributed for 2 conferences

Order
Order list, November 2, 2020 · Certiorari denied

Proceedings

Nov 02 2020
Petition DENIED. Justice Barrett took no part in the consideration or decision of this petition.
Oct 22 2020
Reply of petitioners Hznp Finance Limited, et al. filed. (Distributed)
Oct 14 2020
DISTRIBUTED for Conference of 10/30/2020.
Sep 30 2020
Brief of respondent Actavis Laboratories UT, Inc. in opposition filed.
Aug 31 2020
Response Requested. (Due September 30, 2020)
Aug 19 2020
DISTRIBUTED for Conference of 9/29/2020.
Aug 11 2020
Waiver of right of respondent Actavis Laboratories UT, Inc. to respond filed.
Jul 24 2020
Petition for a writ of certiorari filed. (Response due August 28, 2020)